Tissue Based Small Animal Model for HIV Drug Discovery

该合同的目的是通过在具有良好特征的SCID-hu Thy/Liv模型小动物模型中进行临床前测试，进一步开发用于HIV- 1的新型疗法（低分子量有机分子，生物制剂和工程病毒）。 该合同的主要科学职能如下： 1.在体外模型中评估HIV治疗方法 2.在经验证的小动物模型中评价体内潜在的HIV-1治疗方法 3.维持病毒储备液、供体组织和复溶免疫缺陷小鼠的质量控制/保证 4.进一步表征或开发动物模型，并适应新发现的模型 5.采集动物组织和/或体液样本，并准备此类样本用于运输

The objective of this contract is to further the preclinical development of novel therapies (low molecular weigh organic molecules, biologics, and engineered viruses) for HIV- 1 through pre-clinical testing in the well characterized SCID-hu Thy/Liv modle small animal model. The major scientific functions of this contract are listed below: 1. Evaluate HIV therapeutics in an in vitro model 2. Evaluate potential HIV-1 therapeutics in vivo in a validated small-animal model 3. Maintain quality control/assurance of viral stocks, donor tissue, and reconstituted immunodeficient mice 4. Further characterize or develop the animal model and adapt newly discovered models 5. Collect samples of animal tissues and/or fluids and prepare such samples for shipment